Hypoxia-mediated regulation of gene expression in mammalian cells

International Journal of Experimental Pathology

Volumn 79, Issue 6, 1998, Pages 347-357

  Shih, Shu Ching ^a   Claffey, Kevin P ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Expression; Gene; Hypoxia; Regulation

Indexed keywords

ERYTHROPOIETIN; GLUCOSE TRANSPORTER; GLYCOLYTIC ENZYME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; CATECHOLAMINE RELEASE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HYPOXIA; MAMMAL CELL; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN PROCESSING; REPORTER GENE; REVIEW; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL HYPOXIA; GENE EXPRESSION REGULATION; HUMANS; MAMMALS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0032407157     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1998.00088.x     Document Type: Review

References (86)

1. ABATE C., PATEL L., RAUSCHER F.J. & CURRAN T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science 249, 1157-1161.
2. ANGEL P., HATTORI K., SMEAL T. & KARIN M. (1988) The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875-885.
3. AUSSERER W.A., BOURRAT-FLOECK B., GREEN C.J., LADEROUTE K.R. & SUTHERLAND R.M. (1994) Regulation of c-jun expression during hypoxic and low-glucose stress. Mol. Cell. Biol. 14, 5032-5042.
4. BASHAN N., BURDETT E., HUNDAL H.S. & KLIP A. (1992) Regulation of glucose transport and GLUT1 glucose transporter expression by O2 in muscle cells in culture. Am. J. Physiol. 262, C682-C690.
5. BLANCHARD K.L., ACQUAVIVA A.M., GALSON D.L. & BUNN H.F. (1992) Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol. Cell. Biol. 12, 5373-5385.
6. BREWER G. & ROSS J. (1988) Poly (A) shortening and degradation of the 3′ A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol. Cell. Biol. 8, 1697-1708.
7. BUNN H.F. & POYTON R.O. (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76, 839-885.
8. CHEN C.-Y.A. & SHYU A.-B. (1995) AU-rich elements: characterization and importance of mRNA degradation. TIBS 20, 465-470.
9. CHIU R., BOYLE W.J., MEEK J., SMEAL T., HUNTER T. & KARIN M. (1988) The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541-552.
10. CLAFFEY K.P., SHIH S.-C., MULLEN A. ET AL. (1998) Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell 9, 469-481.
11. CLAFFEY K.P., WILKISON W.O. & SPIEGELMAN B.M. (1992) Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267, 16317-16322.
12. CZYZYK-KRZESKA M.F., FURNARI B.A., LAWSON E.E. & MILLHORN D.E. (1994) Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem. 269, 760-764.
13. CZYZYK-KRZESKA M.F. & BERESH J.E. (1996) Characterization of the hypoxia-inducible protein binding site within the pyrimidine-rich tract in the 3′-untranslated region of the tyrosine hydroxylase mRNA. J. Biol. Chem. 271, 3293-3299.
14. CZYZYK-KRZESKA M.F., PAULDING W.R., BERESH J.E. & KROLL S.L. (1997) Post-transcriptional regulation of tyrosine hydroxylase gene expression by oxygen in PC12 cells. Kidney Int. 51, 585-590.
15. DECKER C.J. & PARKER R. (1995) Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell. Biol. 7, 386-392.
16. EBERT B.L., FIRTH J.D. & RATCLIFFE P.J. (1995) Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270, 29083-29089.
17. EBERT B.L., GLEADLE J.M.O., ROURKE J.F., BARTLETT S.M., POULTON J. & RATCLIFFE P.J. (1996) Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem. J. 313, 809-814.
18. FAQUIN W.C., SCHNEIDER T.J. & GOLDBERG M.A. (1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79, 1987-1994.
19. FAQUIN W.C., SCHNEIDER T.J. & GOLDBERG M.A. (1993) Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production. Exp. Hematol. 21, 420-426.
20. FINKENZELLER G., MARINE D., WEICH H.A. & HUG H. (1992) Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res. 52, 4821-4823.
21. FIRTH J.D., EBERT B.L., PUGH C.W. & RATCLIFFE P.J. (1994) Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3' enhancer. Proc. Natl. Acad. Sci. U.S.A. 91, 6496-6500.
22. GALSON D.L., TSUCHIYA T., TENDLER D.S. ET AL. (1995) The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythro-poietin gene expression and is antagonized by EAR3/COUP-TF1. Mol. Cell. Biol. 15, 2135-2144.
23. GOLDBERG M.A., GLASS G.A., CUNNINGHAM J.M. & BUNN H.F. (1987) The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. USA. 84, 7972-7976.
24. GOLDBERG M.A., DUNNING S.P. & BUNN H.F. (1988) Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242, 1412-1415.
25. GOLDBERG M.A. & SCHNEIDER T.J. (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269, 4355-4359.
26. GRAVEN K.K., TROXLER R.F., KORNFELD H., PANCHENKO M.V. & FARBER H.W. (1994) Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J. Biol. Chem. 269, 24446-24453.
27. GRUGERL S., FINKENSELLER G., WEINDEL K., BARLEON B. & MARME D. (1995) Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270, 25915-25919.
28. HAMILTON B.J., NAGY E., MALTER J.S., ARRICK B.A. & RIGBY W.F.C. (1993) Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem. 268, 8881-8887.
29. HELFMAN T. & FALANGA V. (1993) Gene expression in low oxygen tension. Am. J. Med. Sci. 306, 37-41.
30. HO V., ACQUAVIVA A., DUH E. & BUNN H.F. (1995) Use of a marked erythropoietin gene for investigation of its cis-acting elements. J. Biol. Chem. 270, 10084-10090.
31. HUANG LE., ARANY Z., LIVINGSTON D.M. & BUNN H.F. (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha sub-unit. J. Biol. Chem. 271, 32253-32259.
32. IKEDA E., ACHEN M.G., BREIER G. & RISAU W. (1995) Hypoxiainduced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19761-19766.
33. JELKMANN W. (1992) Erythropoietin: structure, control of production, and function. Physiol. Rev. 72, 449-489.
34. KIESER A., WEICH H.A., BRANDNER G., MARME D. & KOLCH W. (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9, 963-969.
35. KIETZMANN T., SCHMIDT H., UNTHAN-FECHNER K., PROBST I. & JUNGERMANN K. (1993) A ferro-heme protein senses oxygen levels, which modulate the glucagon-dependent activation of the phosphoenolpyruvate carboxykinase gene in rat hepatocyte cultures. Biochem. Biophys. Res. Commun. 195, 792-798.
36. KILEDJIAN M., WANG X. & LIEBHABER S.A. (1995) Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J. 14, 4357-4364.
37. KOONG A.C., CHEN E.Y. & GIACCIA A.J. (1994a) Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 54, 1425-1430.
38. KOONG A.C., CHEN E.Y., MIVECHI N.F., DENKO N.C., STAMBROOK P. & GIACCIA A.J. (1994b) Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54, 5273-5279.
39. KUROKI M., VOEST E.E., AMANO S. ET AL. (1996) Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98, 1667-1675.
40. LEVINE T.D., GAO F., KING P.H., ANDREWS L.G. & KEENE J.D. (1993) Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13, 3494-3504.
41. LEVY A.P., LEVY N.S., WEGNER S. & GOLDBERG M.A. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333-13340.
42. LEVY A.P., LEVY N.S. & GOLDBERG M.A. (1996a) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem. 271, 25492-25497.
43. LEVY A.P., LEVY N.S. & GOLDBERG M.A. (1996b) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271, 2746-2753.
44. LEVY N.S., CHUNG S., FURNEAUX H. & LEVY A.P. (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273, 6417-6423.
45. LIU Y., COX R., MOHITA T. & KOUREMBANAS S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ Enhancer. Circ. Res. 77, 638-643.
46. LIU Y., CHRISTOU H., MORITA T., LAUGHNER E., SEMENZA G.L. & KOUREMBANAS S. (1998) Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5 enhancer. J. Biol. Chem. 273, 15257-15262.
47. MAY M.J. & GHOSH S. (1998) Signal transduction through NF-kappa B. Immunol. Today 19, 80-88.
48. MCGARY E.G., RONDON I.J. & BECKMAN B.S. (1997) Post-transcriptional regulation of erythropoietin mRNA stability by erythropoietin mRNA-binding protein. J. Biol. Chem. 272, 8628-8634.
49. MILLHORN D.E., RAYMOND R., CONFORTI L. ET AL. (1997) Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxia. Kidney Int. 51, 527-535.
50. MINCHENKO A., BAUER T., SALCEDA S. & CARO J. (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71, 374-379.
51. MUKHOPADHYAY D., TSIOKAS L., ZHOU X.M., FOSTER D., BRUGGE J.S. & SUKHATME V.P. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375, 577-581.
52. MULLNER E.W. & KUHN L.C. (1988) A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53, 815-825.
53. MURAKAMI T., NISHIYAMA T., SHIROTANI T. ET AL. (1992) Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J. Biol. Chem. 267, 9300-9306.
54. NORRIS M.L. & MILLHORN D.E. (1995) Hypoxia-induced protein binding to O2-responsive sequences on the tyrosine hydroxylase gene. J. Biol. Chem. 270, 23774-23779.
55. PAL S., CLAFFEY K.P., DVORAK H.F. & MUKHOPADHYAY D. (1997) The von Hippel-Linau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272, 27509-27512.
56. PANDEY N.B., SUN J.H. & MARZLUFF W.F. (1991) Different complexes are formed on the 3′ end of histone mRNA with nuclear and polyribosomal proteins. Nucleic Acids Res. 19, 5653-5659.
57. RONDON I.J., MACMILLAN L.A., BECKMAN B.S. ET AL. (1991) Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J. Biol. Chem. 266, 16594-16598.
58. Ross J. (1995) mRNA stability in mammalian cells. Microbiol. Rev. 59, 423-450.
59. SALCEDA S. & CARO J. (1997) Hypoxia-inducible factor 1alpha (HIF-1 alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647.
60. SCANDURRO A.B., RONDON I.J., WILSON R.B., TENENBAUM S.A., GARRY R.F. & BECKMAN B.S. (1997) Interaction of erythropoietin RNA binding protein with erythropoietin RNA requires an association with heat shock protein 70. Kidney Int. 51, 579-584.
61. SEMENZA G.L. & WANG G.L. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
62. SEMENZA G.L., ROTH P.H., FANG H.M. & WANG G.L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763.
63. SENGER D.R., VAN DE WATER L., BROWN L.F. ET AL. (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Met. Rev. 12, 303-324.
64. SHAW G. & KAMEN R. (1986) A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
65. SHIMA D.T., KUROKI M., DEUTSCH U., NG Y.S., ADAMIS A.P. & D'AMORE P.A. (1996) The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271, 3877-3883.
66. SHWEIKI D., ITIN A., SOFFER D. & KESHET E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
67. SHYU A.-B., GREENBERG M.E. & BELASCO J.G. (1989) The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes and Develop. 3, 60-72.
68. SHYU A.-B., BELASCO J.G. & GREENBERG M.E. (1991) Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes and Develop. 5, 221-231.
69. SIMPSON I.A. & CUSHMAN S.W. (1986) Hormonal regulation of mammalian glucose transport. Annu. Rev. Biochem. 55, 1059-1089.
70. STEIN I., NEEMAN M., SHWEIKI D., ITIN A. & KESHET E. (1995) Stabilization of vascular endothelial growth factor mRNA byhypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15, 5363-5368.
71. TISCHER E., MITCHELL R., HARTMAN T. ET AL. (1991) The human gene for vascular endothelial growth factor. J. Biol. Chem. 266, 11947-11954.
72. TOLEDANO M.B. & LEONARD W.J. (1991) Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88, 4328-4332.
73. VOGT P.K. & BOS T.J. (1990) jun: oncogene and transcription factor. Adv. Cancer Res. 55, 1-35.
74. WANG G.L. & SEMENZA G.L. (1993a) Characterization of hypoxiainducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268, 21513-21518.
75. WANG G.L. & SEMENZA G.L. (1993b) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610-3615.
76. WANG G.L. & SEMENZA G.L. (1993c) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90, 4304-4308.
77. WANG G.L., JIANG B.H., RUE E.A. & SEMENZA G.L. (1995a) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
78. WANG X., KILEDJIAN M., WEISS I.M. & LIEBHABER S.A. (1995b) Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability. Mol. Cell. Biol. 15, 1769-1777.
79. WEBSTER K.A. (1987) Regulation of glycolytic enzyme RNA transcriptional rates by oxygen availability in skeletal muscle cells. Mol. Cell. Biochem. 77, 19-28.
80. WEBSTER K.A., GUNNING P., HARDEMAN E., WALLACE D.C. & KEDES L. (1990) Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts. J. Cell. Physiol. 142, 566-573.
81. WEBSTER K.A., DISCHER D.J. & BISHOPRIC N.H. (1993) Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem. 268, 16852-16858.
82. WHITE F.C., CARROLL S.M. & KAMPS M.P. (1995) VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors 12, 289-301.
83. WIENER C.M., BOOTH G. & SEMENZA G.L. (1996) In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225, 485-488.
84. WOOD S.M., GLEADLE J.M., PUGH C.W., HANKINSON O. & RATCLIFFE P.J. (1996) The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J. Biol. Chem. 271, 15117-15123.
85. WOOD S.M., WIESENER M.S., YEATES K.M., OKADA N., PUGH C.W., MAXWELL P.M. & RATCLIFFE P.J. (1998) Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif-1alpha-dependent and -independent hypoxia-inducible gene expression. J. Biol. Chem. 273, 8360-8368.
86. ZHANG W., WAGNER B.J., EHRENMAN K., SCHAEFER A.W., DEMARIA C.T., CRATER D., DEHAVEN K., LONG L. & BREWER G. (1993) Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13, 7652-7665.